Literature DB >> 2547999

Cloning and expression of foreign genes in vaccinia virus, using a host range selection system.

M E Perkus1, K Limbach, E Paoletti.   

Abstract

A simple selection system has been developed for the cloning and expression of open reading frames in vaccinia virus. The selection system is based on a conditional lethal (host range) mutant of vaccinia virus. A deletion mutant of the vaccinia virus WR strain was generated by insertion of the neomycin resistance gene from transposon Tn5 and selection with the antibiotic G418. This deletion recombinant, vP293, lacked approximately 21.7 kilobases of DNA beginning 3.8 kilobases from the left end of the genome, vP293, was capable of plaquing on primary chicken embryo fibroblasts and two monkey cell lines (BSC-40 and Vero) but was defective in replication in the human cell line MRC-5. Insertion of the host range gene K1L into vP293 restored the ability to grow on MRC-5 cells. A series of plasmids were constructed which in addition to the K1L gene contained a vaccinia virus early-late promoter, H6, followed by a unique polylinker sequence, translational initiation and termination signals, and an early transcription termination signal. These plasmids, pHES1 through 4, allowed for rapid single-step cloning and expression of any open reading frame when recombined in vivo with vP293 and scored for growth on MRC-5 cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547999      PMCID: PMC250976          DOI: 10.1128/JVI.63.9.3829-3836.1989

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Vaccinia virus as an expression vector.

Authors:  A Piccini; M E Perkus; E Paoletti
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

2.  Transformation of rat cells by DNA of human adenovirus 5.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-08       Impact factor: 3.616

3.  Host range restriction of vaccinia virus in Chinese hamster ovary cells: relationship to shutoff of protein synthesis.

Authors:  R Drillien; D Spehner; A Kirn
Journal:  J Virol       Date:  1978-12       Impact factor: 5.103

4.  Two major DNA variants present in serially propagated stocks of the WR strain of vaccinia virus.

Authors:  D Panicali; S W Davis; S R Mercer; E Paoletti
Journal:  J Virol       Date:  1981-03       Impact factor: 5.103

5.  Host range deletion mutant of vaccinia virus defective in human cells.

Authors:  R Drillien; F Koehren; A Kirn
Journal:  Virology       Date:  1981-06       Impact factor: 3.616

6.  Particle heterogeneity in vaccinia virus populations during passage.

Authors:  J D Gangemi; D G Sharp
Journal:  Virology       Date:  1978-03       Impact factor: 3.616

7.  The white pock mutants of rabbit poxvirus. I. Spontaneous host range mutants contain deletions.

Authors:  R W Moyer; C T Rothe
Journal:  Virology       Date:  1980-04-15       Impact factor: 3.616

8.  Deletions of the terminal sequences in the genomes of the white pock (u) and host-restricted (p) mutants of rabbitpox virus.

Authors:  J R Lake; P D Cooper
Journal:  J Gen Virol       Date:  1980-05       Impact factor: 3.891

9.  Conditional lethal mutants of rabbitpox virus. I. Isolation of host cell-dependent and temperature-dependent mutants.

Authors:  J F Sambrook; B L Padgett; J K Tomkins
Journal:  Virology       Date:  1966-04       Impact factor: 3.616

10.  Cellular differences in the molecular mechanisms of vaccinia virus host range restriction.

Authors:  D E Hruby; D L Lynn; R C Condit; J R Kates
Journal:  J Gen Virol       Date:  1980-04       Impact factor: 3.891

View more
  48 in total

1.  Recombinant vaccinia viruses. Design, generation, and isolation.

Authors:  C C Broder; P L Earl
Journal:  Mol Biotechnol       Date:  1999-12-15       Impact factor: 2.695

2.  Nipah virus: vaccination and passive protection studies in a hamster model.

Authors:  V Guillaume; H Contamin; P Loth; M-C Georges-Courbot; A Lefeuvre; P Marianneau; K B Chua; S K Lam; R Buckland; V Deubel; T F Wild
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

3.  Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees.

Authors:  Mohamed Tarek Shata; Nancy Tricoche; Marion Perkus; Darley Tom; Betsy Brotman; Patricia McCormack; Wolfram Pfahler; Dong-Hun Lee; Leslie H Tobler; Michael Busch; Alfred M Prince
Journal:  Virology       Date:  2003-09-30       Impact factor: 3.616

4.  Temperature-sensitive mutations in the vaccinia virus H4 gene encoding a component of the virion RNA polymerase.

Authors:  E M Kane; S Shuman
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

5.  Generation of hybrid genes and proteins by vaccinia virus-mediated recombination: application to human immunodeficiency virus type 1 env.

Authors:  L Gritz; A Destree; N Cormier; E Day; V Stallard; T Caiazzo; G Mazzara; D Panicali
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

6.  Characterization of a natural mutation in an antigenic site on the fusion protein of measles virus that is involved in neutralization.

Authors:  J Fayolle; B Verrier; R Buckland; T F Wild
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

7.  Transient dominant selection of recombinant vaccinia viruses.

Authors:  F G Falkner; B Moss
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

8.  Functional analysis of N-linked glycosylation mutants of the measles virus fusion protein synthesized by recombinant vaccinia virus vectors.

Authors:  G Alkhatib; S H Shen; D Briedis; C Richardson; B Massie; R Weinberg; D Smith; J Taylor; E Paoletti; J Roder
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

9.  p53 as a target for cancer vaccines: recombinant canarypox virus vectors expressing p53 protect mice against lethal tumor cell challenge.

Authors:  J Roth; D Dittmer; D Rea; J Tartaglia; E Paoletti; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

Review 10.  Progress in the development of vaccines for hepatitis C virus infection.

Authors:  Faezeh Ghasemi; Sina Rostami; Zahra Meshkat
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.